• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内镜下胰腺引流术改善不可切除胰腺癌患者的外分泌胰腺功能:一项双盲、前瞻性、随机、单中心、干预性研究。

Endoscopic Pancreatic Drainage Improves Exocrine Pancreatic Function in Patients With Unresectable Pancreatic Cancer: A Double-Blind, Prospective, Randomized, Single-Center, Interventional Study.

机构信息

Health Research Institute of Santiago de Compostela (IDIS), University Hospital of Santiago de Compostela, Santiago de Compostela, Spain.

出版信息

Pancreas. 2021;50(5):679-684. doi: 10.1097/MPA.0000000000001817.

DOI:10.1097/MPA.0000000000001817
PMID:34016887
Abstract

OBJECTIVES

Exocrine pancreatic insufficiency is a frequent and clinically relevant complication of pancreatic cancer probably secondary to pancreatic duct obstruction. We aimed at evaluating the impact of endoscopic pancreatic drainage on pancreatic function in patients with unresectable pancreatic cancer.

METHODS

A double-blind, prospective, randomized, single-center, interventional study was designed. Patients undergoing endoscopic retrograde cholangiopancreatography for jaundice secondary to unresectable pancreatic cancer were randomized to biliary drainage (group A) or biliopancreatic drainage (group B). Pancreatic function was evaluated by 13C-mixed triglyceride breath test before and 2 weeks after endoscopic retrograde cholangiopancreatography. Breath test result is expressed as 13C-cumulative recovery rate. Abdominal symptoms and nutritional markers were evaluated as secondary outcomes.

RESULTS

Twenty patients were included. Sixteen patients had exocrine pancreatic insufficiency, and 13 completed the study (7 in group A and 6 in group B). The median absolute improvement of 13C-cumulative recovery rate was of 23.75% (interquartile range, 9.62-31.74) after biliopancreatic drainage compared with -1.92% (interquartile range, -4.17 to 13.92) after biliary drainage (P = 0.015). Nutritional markers improved after biliopancreatic drainage, but not after biliary drainage.

CONCLUSIONS

Biliopancreatic and not biliary endoscopic drainage is associated with a significant improvement of exocrine pancreatic function in patients with unresectable pancreatic cancer.

摘要

目的

外分泌胰腺功能不全是胰腺癌的一种常见且具有临床意义的并发症,可能继发于胰管阻塞。我们旨在评估内镜胰腺引流术对不可切除胰腺癌患者胰腺功能的影响。

方法

设计了一项双盲、前瞻性、随机、单中心、干预性研究。因不可切除的胰腺癌所致的黄疸而行内镜逆行胰胆管造影术的患者被随机分为胆道引流组(A 组)或胰胆管引流组(B 组)。在接受内镜逆行胰胆管造影术之前和之后 2 周,通过 13C-混合三酸甘油酯呼吸试验评估胰腺功能。呼吸试验结果以 13C-累积回收率表示。将腹部症状和营养标志物作为次要结局进行评估。

结果

共纳入 20 例患者。16 例患者存在外分泌胰腺功能不全,其中 13 例完成了研究(A 组 7 例,B 组 6 例)。与胆道引流相比,胰胆管引流后 13C-累积回收率的绝对改善中位数为 23.75%(四分位距,9.62-31.74),而胆道引流后为-1.92%(四分位距,-4.17 至 13.92)(P = 0.015)。胰胆管引流后营养标志物改善,但胆道引流后无改善。

结论

与胆道引流相比,不可切除的胰腺癌患者行胰胆管引流与外分泌胰腺功能的显著改善相关。

相似文献

1
Endoscopic Pancreatic Drainage Improves Exocrine Pancreatic Function in Patients With Unresectable Pancreatic Cancer: A Double-Blind, Prospective, Randomized, Single-Center, Interventional Study.内镜下胰腺引流术改善不可切除胰腺癌患者的外分泌胰腺功能:一项双盲、前瞻性、随机、单中心、干预性研究。
Pancreas. 2021;50(5):679-684. doi: 10.1097/MPA.0000000000001817.
2
Histological loss of pancreatic exocrine cells correlates with pancreatic exocrine function after pancreatic surgery.胰腺手术后胰腺外分泌细胞的组织学丢失与胰腺外分泌功能相关。
Pancreas. 2012 Aug;41(6):928-33. doi: 10.1097/MPA.0b013e31823d837d.
3
A prospective assessment of the natural course of the exocrine pancreatic function in patients with a pancreatic head tumor.对胰头肿瘤患者外分泌胰腺功能自然病程的前瞻性评估。
J Clin Gastroenterol. 2014 May-Jun;48(5):e43-6. doi: 10.1097/MCG.0b013e31829f56e7.
4
13C-mixed triglyceride breath test for evaluation of pancreatic exocrine function in diabetes mellitus.用于评估糖尿病患者胰腺外分泌功能的13C混合甘油三酯呼气试验
Pancreas. 2014 Aug;43(6):842-8. doi: 10.1097/MPA.0000000000000121.
5
Pancreatic function assessment.胰腺功能评估。
Eur Rev Med Pharmacol Sci. 2013;17 Suppl 2:65-71.
6
Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis.晚期胰腺癌患者的胰腺外分泌功能不全和胰腺酶替代治疗:系统评价和荟萃分析。
United European Gastroenterol J. 2020 Nov;8(9):1115-1125. doi: 10.1177/2050640620938987. Epub 2020 Jul 6.
7
Prospective assessment of the influence of pancreatic cancer resection on exocrine pancreatic function.前瞻性评估胰腺癌切除术对外分泌胰腺功能的影响。
Br J Surg. 2014 Jan;101(2):109-13. doi: 10.1002/bjs.9342. Epub 2013 Dec 16.
8
Endoscopic treatment with transmural drainage and necrosectomy for walled-off necrosis provides favourable long-term outcomes on pancreatic function.内镜下经壁引流和坏死组织清除术治疗胰腺假性囊肿可获得有利的长期胰腺功能结局。
United European Gastroenterol J. 2020 Jun;8(5):552-558. doi: 10.1177/2050640620916029. Epub 2020 Apr 23.
9
Endoscopic biliary drainage in unresectable biliary obstruction: the role of endoscopic ultrasound-guidance in a cohort study.不可切除性胆道梗阻的内镜下胆道引流:内镜超声引导在队列研究中的作用。
Rev Esp Enferm Dig. 2019 Sep;111(9):683-689. doi: 10.17235/reed.2019.6225/2019.
10
Identification of risk factors for pancreatic exocrine insufficiency after pancreaticoduodenectomy using a 13C-labeled mixed triglyceride breath test.使用13C标记的混合甘油三酯呼气试验识别胰十二指肠切除术后胰腺外分泌功能不全的危险因素。
World J Surg. 2015 Feb;39(2):516-25. doi: 10.1007/s00268-014-2832-4.

引用本文的文献

1
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations.欧洲胰腺外分泌功能不全诊断与治疗指南:UEG、EPC、EDS、ESPEN、ESPGHAN、ESDO和ESPCG基于证据的建议。
United European Gastroenterol J. 2025 Feb;13(1):125-172. doi: 10.1002/ueg2.12674. Epub 2024 Dec 5.
2
Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma.利用胰腺外分泌功能不全检测可切除性胰腺导管腺癌
Cancers (Basel). 2023 Dec 8;15(24):5756. doi: 10.3390/cancers15245756.
3
Impact of sarcopenia on biliary drainage during neoadjuvant therapy for pancreatic cancer.
肌肉减少症对胰腺癌新辅助治疗期间胆汁引流的影响。
Clin Endosc. 2024 Jan;57(1):112-121. doi: 10.5946/ce.2022.278. Epub 2023 Jul 18.